Description
CYFLOX 250 TAB is an oral broad-spectrum antibiotic tablet formulated with Ciprofloxacin 250 mg, a fluoroquinolone antibiotic effective against a wide range of Gram-positive and Gram-negative bacteria. It is widely prescribed for treating mild to moderate bacterial infections across various systems in the body.
Mechanism of Action:
Ciprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes critical for DNA replication, transcription, and repair. This leads to the elimination of bacterial cells and resolution of infection.
Therapeutic Uses:
Urinary Tract Infections (UTIs)
Respiratory tract infections (bronchitis, pneumonia)
Gastrointestinal infections (e.g., typhoid fever, traveler’s diarrhea)
Skin and soft tissue infections
Sinusitis, prostatitis, and bone infections
Occasionally used in anthrax exposure protocols
Key Benefits:
Rapid bactericidal action against common and resistant pathogens
Convenient oral administration
Well-tolerated in adults with proper dosage control
Useful in empiric therapy before culture sensitivity reports
Manufactured in WHO-GMP and ISO-certified facilities, CYFLOX 250 TAB is exported by BLUEPILL EXPRESS, a globally recognized pharmaceutical supplier with a presence in Asia, Africa, Latin America, the Middle East, and Europe. BLUEPILL EXPRESS ensures quality assurance, full documentation, and timely export service for international markets.

